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Developing Criteria for a Paediatric 
Triage Tool
to aid prioritisation of patients by 
Clinical and Pharmaceutical Care Issues
 Triaging adult patients by pharmaceutical care issues identifies those at higher 
risk and in most need of care/treatment
 The nature and type of medical errors & subsequent delivery of  care differs 
considerably in children compared with adults
 LLWWOHLQIRUPDWLRQDYDLODEOHRQWKHXVHRI¶7ULDJH7RROV·LQWKHSDHGLDWULFRU
neonatal setting
 Aim - To develop a paediatric triage tool and investigate the feasibility of its 
implementation into routine practice using a consensus approach amongst 
expert paediatric and neonatal clinical pharmacists. 
Background
 Delphi Methodology used ʹ allows a consensus approach to be taken. 
 Members of the Scottish Neonatal & Paediatric Pharmacy Group (SNAPP) invited to 
take part via email (N = 42)
 Statements describing scenarios to allow the prioritisation of paediatric and 
neonatal patients were created based upon clinical practice and the relevant 
literature
 Statements and scenarios formatted as a self administered questionnaires which 
was  distributed via Qualtrics© (online survey platform)
 Five-point Likert scale response 
 Comments box included for ¶MXVWLILFDWLRQ·
of response
Method
Strongly
Agree
Agree Neither 
Agree nor 
Disagree
Disagree Strongly 
Disagree
1 2 3 4 5
 Mean and mode responses calculated for each questionnaire item (statement). This 
identified them most popular response and the sample average.  
 Content analysis was undertaken to provide a textual background to subsequent 
themes
 NHS Lothian Pharmacy Quality Improvement Team Approval sought
DĞƚŚŽĚ ?ĐŽŶƚ ?Ě ?
Literature 
Review
Delphi 
Round 
One
(SNAPP N=12)
Delphi 
Round 
Two
(SNAPP N=11)
Delphi 
Round 
Three 
(SNAPP N=7)
Draft 
Triage 
Tool
 I feel there needs to be something here ² DVZHGRQ·WNQRZZKDWWKHKUV
hrs actually refers to in the next slide? Or the red/amber colours?
 Would it be helpful/make sense if part of the survey was shown here ? 
 Stable, chronic renal failure or acute, mild kidney injury
 Chronic hepatic impairment
 High risk medicines
 Daily aseptic need
 Unstable, chronic renal failure or acute, severe/moderate kidney injury
 Acute hepatic impairment
 Renal replacement
 ECMO or plasmapheresis
Medicine is being withheld due to administration issues
 Prescribed continuous infusions
24 
hourly
 Stable patients with no acute issues
48 
hourly
72 
hourly
Results
 Patients on psychotropic medicines should be review daily
 Patient with a perceived discharge issue should be seen daily
All paediatric & neonatal patients should be reviewed daily
 Stable patients can be reviewed at 14 days or re-referral
 Patients prescribed unlicensed / off-label medicine should be reviewed daily
 Patients prescribed >5 regular medicines should be review daily
 Patients receiving renal replacement should only be seen daily if they are 
unstable
 Patients with stable or unstable renal failure should be reviewed daily only if 
changes to their medication have occurred
 Patients with acute, moderate and severe kidney injury should be reviewed 
daily only if changes to their medication have occurred
ZĞƐƵůƚƐĐŽŶƚ ?Ě
?
X
 Maximum of three days left between reviews ² unlike adult practice where there can be 
to 14 days between review.
 6LQFHPXOWLSOHPHGLFLQHVDUH¶XQOLFHQVHG·RU¶RII-ODEHO·LQWKLVSDWLHQWJURXS- it was not 
considered an important??? / suitable criteria
 Both medication and fluid continuous infusions require daily review 
 Psychotropic medication classed as high risk due to unfamiliarity with tat type of 
medication 
 Varying requirement for review depending on degree of renal and kidney failure 
regardless of what medication is prescribed
 Polypharmacy in itself does not increase the need for review
Discussion
 75% of pharmacists on expert panel were based in a paediatric 
hospital - Generalisable? 
 Statements referred to both paediatric and neonatal patients
 /DFNLQJLQDVWDWLVWLFDOO\UREXVWDSSURDFKWR¶LWHP·YDOLGDWLRQi.e no 
factor analysis performed or content/scale item analysis). 
 Response rate for round three was below the generally accepted 
level
 Further work will include piloting the tool on a small number of 
paediatric and neonatal patients
Limitations & Further Work
 Participants agreed that a triage tool would be beneficial in the 
paediatric and neonatal setting
 The tool would allow pharmacists to focus their expertise in areas 
of most need to maximise pharmacist skills and increase patient 
safety
 18 criteria have been agreed upon which categorise patients into one 
of three groups: review 24 hourly,  review 48 hourly or review 72 
hourly
Conclusion

